Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current Assets:
Cash and cash equivalents	$ 12,942,507	$ 15,524,378
Accounts receivable, net	1,692,573	1,960,037
Inventories, net	1,028,767	808,308
Prepaid expenses and other current assets	940,929	799,164
Total Current Assets	16,604,776	19,091,887
Operating lease assets with right of use	781,917	632,906
Equipment, net	279,538	275,289
Investment in Jiangxi Myomo Medical Assistive Appliance Co. Ltd.	199,000
Other assets	111,409	95,330
Total Assets	17,976,640	20,095,412
Current Liabilities:
Accounts payable and accrued expenses	4,240,213	3,949,784
Current operating lease liability	410,497	333,380
Deferred revenue	1,899	249
Total Current Liabilities	4,652,609	4,283,413
Deferred revenue	1,246	1,246
Non-current operating lease liability	453,073	401,622
Total Liabilities	5,106,928	4,686,281
Commitments and Contingencies
Stockholders’ Equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued or outstanding
Common stock par value $0.0001 per share, 65,000,000 shares authorized; 6,879,904 and 6,869,753 shares issued as of March 31, 2022 and December 31, 2021, respectively; and 6,879,877 and 6,869,726 shares outstanding at March 31, 2022 and December 31, 2021, respectively	688	687
Additional paid-in capital	93,804,076	93,537,807
Accumulated other comprehensive loss	(51,432)	(60,677)
Accumulated deficit	(80,877,156)	(78,062,222)
Treasury stock, 27 shares at cost	(6,464)	(6,464)
Total Stockholders’ Equity	12,869,712	15,409,131
Total Liabilities and Stockholders’ Equity	$ 17,976,640	$ 20,095,412